Anna Kazanchyan insider trades: Foamix Pharmaceuticals (FOMX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anna reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 26, 2019 | FOMX | ↓ Sell | 7,049 | $3.27 | $23K | Direct | Aug 28, 2019 (2d) |
| Jul 15, 2019 | FOMX | ↓ Sell | 808 | $2.31 | $2K | Direct | Jul 17, 2019 (2d) |
| May 20, 2019 | FOMX | ↓ Sell | 10,600 | $2.61 | $28K | Direct | May 20, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Anna Kazanchyan's insider trades
Anna Kazanchyan is a director at Foamix Pharmaceuticals (FOMX). Since May 20, 2019, Anna has reported no open-market purchases and 3 sales worth $53K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FOMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.